Classification of leprosy into multibacillary and paucibacillary groups: An analysis

FEMS Immunology and Medical Microbiology

Volumn 55, Issue 1, 2009, Pages 1-5

  Parkash, Om ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Bacteriology; Classification; Leprosy; Mycobacterium leprae; Serology; Treatment

Indexed keywords

BACTERIUM ANTIBODY; MYCOBACTERIUM ANTIGEN;

ANTIGEN SPECIFICITY; BACTERIUM EXAMINATION; CELLULAR IMMUNITY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE DURATION; FOLLOW UP; HUMAN; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RELIABILITY; SEROLOGY; SHORT SURVEY; SKIN DEFECT; TREATMENT DURATION;

ANTIBODIES, BACTERIAL; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE;

EID: 58149295904     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00491.x     Document Type: Short Survey

References (37)

1. Antia NH Pandya NJ (1976) Qualitative histology and quantitative bacteriology in various tissues of 50 leprosy patients. Leprosy Rev 47 : 175 183.
2. Bhatia VN, Vanaja G, Rao S Elango TV (1990) Some observations on skin smear examination. Ind J Lep 62 : 338 345.
3. Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR Klatser PR (2000) Use of ML dipstick as a tool to classify leprosy patients. Int J Leprosy 68 : 456 463.
4. Buhrer-Sekula S, Cuhna MG, Foss NT, Oskam L, Faber W R Klatser PR (2001) Dipstick assay to identify leprosy patients who have an increased risk of relapse. Trop Med Int Health 6 : 317 323.
5. Buhrer-Sekula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR Oskam L (2003) Simple and lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microb 41 : 1991 1995.
6. Buhrer-Sekula S, Visschedijk J, Grossi MAF, Dhakal KP, Namadi AU, Klatser PR Oskam L (2007) The ML Flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Leprosy Rev 78 : 271 279.
7. Croft RP, Smith WCS, Nicholls P Richardus JH (1998) Sensitivity and specificity of methods of classification of leprosy without use of skin-smears examination. Int J Leprosy 66 : 445 450.
8. David HL, Papa F, Cruaud P, Berlie HC, Maroja MF, Salem JI Costa MF (1992) Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions and bacteriological loads: implications in the pathogenesis, epidemiological and serodiagnosis of leprosy and tuberculosis. Int J Leprosy 60 : 208 224.
9. Dharmendra (1985) Classification of leprosy. Leprosy (Hastings RC Convit J, eds), pp. 88 99. Churchill Livingstone, Edinburgh.
10. Douglas JT, Steven LM, Fajardo T, Cellona RV, Madarang MG, Abalos RM Steenbergen GJ (1988) The effects of chemotherapy on antibody levels in lepromatous patients. Leprosy Rev 59 : 127 135.
11. Douglas JT, Hirsch DS, Fajardo TT, Cellona RV, Abalos RM, de la Cruz EC, Madarang MG, de Wit MY Klatser PR (1989a) Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines. Leprosy Rev 60 : 8 19.
12. Douglas JT, Hirsch DS, Fajardo TT, Cellona RV, Abalos RM, de la Cruz EC, Madarang MG, de Wit MY Klatser PR (1989b) Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philipines. Leprosy Rev 60 : 178 186.
13. Georgiev GD McDougall AC (1988) Skin smears and the bacterial index (BI) in multiple drug therapy leprosy control programs: an unsatisfactory and potentially hazardous state of affairs. Int J Leprosy 56 : 101 103.
14. Groenen G, Saha NG, Rashid MA, Hamid MA Pattyn SR (1995) Classification of leprosy cases under field conditions in Bangladesh. I. Reliability of clinical criteria. Leprosy Rev 66 : 134 143.
15. Gupte MD, Raj CA, Kannan S Desikan KV (1988) Reliability of direct skin smear microscopy in leprosy. Ind J Lep 60 : 566 571.
16. Kaur S, Sharma VK, Basak P, Kaur I Radotra BD (1993) Concurrent skin and nerve histology in leprosy and its role in the classification of leprosy. Leprosy Rev 64 : 110 116.
17. Kumarasinghe SP Kumarasinghe MP (2004) Should large lesions of leprosy be considered as "Multibacillary" for treatment purposes even if the total number of lesions is less than five? Int J Leprosy 72 : 173 174.
18. Lakshmi TS, Rao PN, Krishna AV, Kumar EC, Lakshmi TS, Rao PN, Krishna AV Kumar EC (1996) Histopathology of skin and nerve and clinical classification in leprosy patients. Ind J Lepr 68 : 258 260.
19. Maeda SM, Rotta O, Michalany NS, Camargo ZP, Sunderkotter C Tomimori-Yamashita J (2003) Comparison between anti-PGL-1 serology and Mitsuda reaction: clinical reading, microscopic findings and immunohistochemical analysis. Leprosy Rev 74 : 263 274.
20. Manandhar R, LeMaster JW, Butlin CR, Brennan PJ Roche PW (2000) Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population. Int J Leprosy 68 : 40 48.
21. Moubasher AA, Kamel NK, Zedan H Raheem DDA (1998) Cytokines in leprosy, 1. Serum cytokine profile in leprosy. Int J Dermatol 37 : 733 740.
22. Nilson R Reddy BB (1989) The role of nerve biopsies in diagnosis and management of leprosy. Leprosy Rev 60 : 28 32.
23. Norman G, Joseph G Richard J (2004) Validity of the WHO operational classification and value of other clinical signs in the classification of leprosy. Int J Leprosy 72 : 278 283.
24. Opromolla DV (2005) Some considerations on the origin of type 1 reactions in leprosy. Int J Leprosy 73 : 33 34.
25. Parkash O, Kumar A, Nigam A Girdhar BK (2006) Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. J Med Microb 55 : 1337 1341.
26. Parkash O, Kumar A, Pandey R, Girdhar BK, Franken KLMC Ottenhoff THM (2007a) Serological heterogeneity against various Mycobacterium leprae antigens and its use in serodiagnosis of leprosy patients. J Med Microb 56 : 1259 1261.
27. Parkash O, Pandey R, Kumar A Kumar A (2007b) Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients. Lett Appl Microbiol 44 : 524 530.
28. Ponnighaus JM, Lienhardt C, Lucas S, Fine PE Sterne JA (1997) Comparison of bacillary indexes in slit-skin smears, skin and nerve biopsies: a study from Malawi. Int J Leprosy 65 : 211 216.
29. Ramanathan VD, Parkash O, Ramu G, Parker D, Curtis J, Sengupta U Turk JL (1984) Isolation and analysis of circulating immune-complexes in leprosy. Clin Immunol Immunopathol 32 : 261 268.
30. Ridley DS Jopling WH (1966) Classification of leprosy according to immunity. A five-group system. Int J Leprosy 34 : 255 273.
31. Roche PW, Britton WJ, Failbus SS, Williams D, Pradhan HM Theuvenet WJ (1990) Operational value of serological response in multibacillary leprosy patients and bacteriological correlates of antibody response. Int J Leprosy 58 : 480 490.
32. Srinivas D, Rao NP, Laxmi TS Suneetha S (2002) Bacterial index of granuloma and its relevance compared to BI of skin smears. Leprosy Rev 73 : 79 80.
33. Talhari S (1996) Diagnosis, classification and prognosis. Int J Leprosy 64 (suppl), s13 s14.
34. Vettom L Pritze S (1989) Reliability of skin smear results: experiences with quality control of skin smears in different routine services in leprosy programmes. Leprosy Rev 60 : 187 196.
35. WHO (1982) Chemotherapy of leprosy for control programmes. Technical report series 675. World Health Organization, Geneva.
36. WHO (1988) Expert Committee on Leprosy: fifth report. Technical report series 678. World Health Organization, Geneva.
37. WHO (1994) Chemotherapy of leprosy. Technical report series 847. World Health Organization, Geneva.